Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ultiseng
- Development stage
- Unknown
- Lead developer
- Medley Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ultiseng is a multi-ingredient nutritional supplement manufactured by Medley Pharmaceuticals. It is formulated as capsules or softgels containing a blend of essential vitamins (including folic acid, methylcobalamin, riboflavin, thiamine, vitamin A, and niacin), minerals (such as elemental copper and manganese), and pine bark extract. Marketed as a daily health supplement, it is intended to support overall well-being, immune function, heart health, and blood health through its antioxidant and anti-inflammatory properties. It is classified as a nutraceutical rather than a pharmaceutical drug with a specific therapeutic target.
- Brand names
- UltisengUltiseng Plus
Beyond the preview
Go deeper on Ultiseng.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ultiseng.